Chemours (CC)
Market Price (12/4/2025): $12.9 | Market Cap: $1.9 BilSector: Materials | Industry: Diversified Chemicals
Chemours (CC)
Market Price (12/4/2025): $12.9Market Cap: $1.9 BilSector: MaterialsIndustry: Diversified Chemicals
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Attractive yieldDividend Yield is 4.2% | Weak multi-year price returns2Y Excs Rtn is -98%, 3Y Excs Rtn is -127% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 160% |
| Megatrend and thematic driversMegatrends include Advanced Materials, and Hydrogen Economy. Themes include Specialty Chemicals for Performance, Green Hydrogen Production, Show more. | Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 30x | |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -5.8%, Rev Chg QQuarterly Revenue Change % is -0.9% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -13% |
| Attractive yieldDividend Yield is 4.2% |
| Megatrend and thematic driversMegatrends include Advanced Materials, and Hydrogen Economy. Themes include Specialty Chemicals for Performance, Green Hydrogen Production, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -98%, 3Y Excs Rtn is -127% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 160% |
| Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 30x |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -5.8%, Rev Chg QQuarterly Revenue Change % is -0.9% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -13% |
Valuation, Metrics & Events
CC Stock
Why The Stock Moved
Qualitative Assessment
AI Generated Analysis | Feedback
Here are five key points highlighting why Chemours (CC) stock moved by -15.2% during the approximate time period from August 31, 2025, to December 4, 2025: 1. Disappointing Q3 2025 Earnings: Chemours reported adjusted Earnings Per Share (EPS) of $0.20 for the third quarter of 2025, which significantly missed analysts' consensus estimates that ranged from $0.24 to $0.27, leading to notable investor dissatisfaction. 2. Weak Fourth Quarter 2025 Outlook: The company issued a cautious forecast for the fourth quarter of 2025, projecting a sequential decline in net sales by 10% to 15% and lower Adjusted EBITDA than anticipated by analysts, which further contributed to negative market sentiment.
Show moreStock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| CC Return | 46% | 40% | -6% | 7% | -44% | -22% | -10% |
| Peers Return | 5% | 91% | -1% | -3% | -8% | -18% | 45% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 16% | 112% |
Monthly Win Rates [3] | |||||||
| CC Win Rate | 75% | 58% | 50% | 42% | 42% | 50% | |
| Peers Win Rate | 58% | 63% | 42% | 47% | 48% | 30% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 70% | |
Max Drawdowns [4] | |||||||
| CC Max Drawdown | -59% | -4% | -30% | -21% | -45% | -43% | |
| Peers Max Drawdown | -55% | -2% | -22% | -21% | -18% | -39% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: EMN, HUN, LXU, CBT, ASH. See CC Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/3/2025 (YTD)
How Low Can It Go
| Event | CC | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -46.6% | -25.4% |
| % Gain to Breakeven | 87.1% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -63.1% | -33.9% |
| % Gain to Breakeven | 171.3% | 51.3% |
| Time to Breakeven | 124 days | 148 days |
| 2018 Correction | ||
| % Loss | -79.0% | -19.8% |
| % Gain to Breakeven | 375.3% | 24.7% |
| Time to Breakeven | Not Fully Recovered days | 120 days |
Compare to EMN, HUN, LXU, CBT, ASH
In The Past
Chemours's stock fell -46.6% during the 2022 Inflation Shock from a high on 6/7/2022. A -46.6% loss requires a 87.1% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
| Title | Topic | Date | |
|---|---|---|---|
| DASHBOARDS | |||
| Chemours Earnings Notes | |||
| Would You Still Hold Chemours Stock If It Fell 30%? | Return | ||
| Chemours (CC) Operating Cash Flow Comparison | Financials | ||
| Chemours (CC) Net Income Comparison | Financials | ||
| Chemours (CC) Debt Comparison | Financials | ||
| Chemours (CC) Revenue Comparison | Financials | ||
| Chemours (CC) EBITDA Comparison | Financials | ||
| Chemours (CC) Operating Income Comparison | Financials | ||
| Chemours (CC) Tax Expense Comparison | Financials | ||
| CC Dip Buy Analysis | |||
| ARTICLES | |||
| Market Movers | Winners: TLRY, STOK, CC | Losers: ACDC, KLC, CAVA | August 14th, 2025 |
Trade Ideas
Select past ideas related to CC. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11212025 | DD | DuPont de Nemours | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 3.1% | 3.1% | -0.2% |
| 11212025 | CF | CF Industries | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 0.5% | 0.5% | -1.1% |
| 11212025 | HL | Hecla Mining | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 30.9% | 30.9% | 0.0% |
| 11072025 | CDE | Coeur Mining | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 12.7% | 12.7% | -5.7% |
| 10312025 | ATR | AptarGroup | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 4.8% | 4.8% | -2.5% |
| 03312023 | CC | Chemours | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -4.8% | -9.2% | -32.0% |
| 04302019 | CC | Chemours | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -52.4% | -63.3% | -78.6% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11212025 | DD | DuPont de Nemours | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 3.1% | 3.1% | -0.2% |
| 11212025 | CF | CF Industries | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 0.5% | 0.5% | -1.1% |
| 11212025 | HL | Hecla Mining | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 30.9% | 30.9% | 0.0% |
| 11072025 | CDE | Coeur Mining | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 12.7% | 12.7% | -5.7% |
| 10312025 | ATR | AptarGroup | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 4.8% | 4.8% | -2.5% |
| 03312023 | CC | Chemours | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -4.8% | -9.2% | -32.0% |
| 04302019 | CC | Chemours | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -52.4% | -63.3% | -78.6% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Chemours
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 35.62 |
| Mkt Cap | 2.3 |
| Rev LTM | 4,798 |
| Op Inc LTM | 92 |
| FCF LTM | 116 |
| FCF 3Y Avg | 90 |
| CFO LTM | 316 |
| CFO 3Y Avg | 240 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | -3.4% |
| Rev Chg 3Y Avg | -5.9% |
| Rev Chg Q | -7.2% |
| QoQ Delta Rev Chg LTM | -1.9% |
| Op Mgn LTM | 4.9% |
| Op Mgn 3Y Avg | 7.2% |
| QoQ Delta Op Mgn LTM | -0.1% |
| CFO/Rev LTM | 9.3% |
| CFO/Rev 3Y Avg | 10.2% |
| FCF/Rev LTM | 2.6% |
| FCF/Rev 3Y Avg | 3.8% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 2.3 |
| P/S | 0.9 |
| P/EBIT | 6.4 |
| P/E | -6.1 |
| P/CFO | 7.1 |
| Total Yield | -1.6% |
| Dividend Yield | 2.5% |
| FCF Yield 3Y Avg | 5.5% |
| D/E | 0.8 |
| Net D/E | 0.6 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 10.1% |
| 3M Rtn | -3.7% |
| 6M Rtn | 7.7% |
| 12M Rtn | -37.7% |
| 3Y Rtn | -40.3% |
| 1M Excs Rtn | 10.1% |
| 3M Excs Rtn | -10.7% |
| 6M Excs Rtn | -7.1% |
| 12M Excs Rtn | -52.0% |
| 3Y Excs Rtn | -111.7% |
Comparison Analyses
Segment Financials
Assets by Segment
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Corporate | 2,813 | 2,152 | 2,338 | 1,860 | 1,811 |
| Titanium Technologies | 2,226 | 2,384 | 2,318 | 2,130 | 2,291 |
| Advanced Performance Materials | 1,833 | 1,742 | 1,621 | 1,520 | 1,521 |
| Thermal & Specialized Solutions | 1,283 | 1,238 | 1,124 | 1,041 | 1,061 |
| Other Non-Reportable Segment | 96 | 124 | 149 | ||
| Chemical Solutions | 531 | 574 | |||
| Total | 8,251 | 7,640 | 7,550 | 7,082 | 7,258 |
Returns Analyses
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 11062025 | 10-Q 9/30/2025 |
| 6302025 | 8052025 | 10-Q 6/30/2025 |
| 3312025 | 5062025 | 10-Q 3/31/2025 |
| 12312024 | 2182025 | 10-K 12/31/2024 |
| 9302024 | 11042024 | 10-Q 9/30/2024 |
| 6302024 | 8012024 | 10-Q 6/30/2024 |
| 3312024 | 4302024 | 10-Q 3/31/2024 |
| 12312023 | 3272024 | 10-K 12/31/2023 |
| 9302023 | 10272023 | 10-Q 9/30/2023 |
| 6302023 | 7282023 | 10-Q 6/30/2023 |
| 3312023 | 4282023 | 10-Q 3/31/2023 |
| 12312022 | 2102023 | 10-K 12/31/2022 |
| 9302022 | 10262022 | 10-Q 9/30/2022 |
| 6302022 | 8012022 | 10-Q 6/30/2022 |
| 3312022 | 5032022 | 10-Q 3/31/2022 |
| 12312021 | 2112022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |